Chengdu Bright Eye Hospital Group Past Earnings Performance
Past criteria checks 0/6
Chengdu Bright Eye Hospital Group has been growing earnings at an average annual rate of 9.7%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 18.1% per year.
Key information
9.7%
Earnings growth rate
2.3%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 18.1% |
| Return on equity | -1.1% |
| Net Margin | -1.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Chengdu Bright Eye Hospital Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,688 | -33 | 996 | 9 |
| 30 Jun 24 | 2,760 | 76 | 979 | 10 |
| 31 Mar 24 | 2,744 | 122 | 953 | 11 |
| 31 Dec 23 | 2,718 | 268 | 917 | 11 |
| 30 Sep 23 | 2,459 | 244 | 836 | 9 |
| 30 Jun 23 | 2,214 | 204 | 791 | 9 |
| 31 Mar 23 | 1,907 | 146 | 725 | 9 |
| 01 Jan 23 | 1,726 | 21 | 696 | 7 |
| 30 Sep 22 | 1,785 | 70 | 679 | 4 |
| 30 Jun 22 | 1,753 | 80 | 659 | 3 |
| 31 Mar 22 | 1,755 | 99 | 647 | 0 |
| 01 Jan 22 | 1,710 | 94 | 627 | 0 |
| 31 Dec 20 | 1,362 | 109 | 425 | 0 |
| 31 Dec 19 | 1,193 | 49 | 410 | 0 |
| 31 Dec 18 | 1,016 | 31 | 358 | 0 |
| 31 Dec 17 | 806 | -13 | 298 | 0 |
Quality Earnings: 301239 is currently unprofitable.
Growing Profit Margin: 301239 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301239 is unprofitable, but has reduced losses over the past 5 years at a rate of 9.7% per year.
Accelerating Growth: Unable to compare 301239's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 301239 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).
Return on Equity
High ROE: 301239 has a negative Return on Equity (-1.11%), as it is currently unprofitable.